Home » Topics » Regulatory

Regulatory
RSS

First iguratimod product approved in China

Aug. 26, 2011

FDA approves Botox for new indication

Aug. 25, 2011

FDA grants accelerated approval to Adcetris for two indications

Aug. 22, 2011

Antimalarial Pyramax obtains approval in Korea

Aug. 22, 2011

FDA approves Intersect ENT's Propel implant

Aug. 18, 2011

Roche obtains FDA approval for melanoma drug and companion diagnostic

Aug. 18, 2011

Nabi Biopharmaceuticals receives another milestone payment from Fresenius

Aug. 17, 2011

FDA approved new strengths of Lupron Depot-PED allowing administration every 3 months

Aug. 17, 2011

FDA approves second single-pill complete antiretroviral therapy for untreated HIV-1 infection

Aug. 12, 2011

Zoely is approved in the E.U.

Aug. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...